Retina Consultants picks AllyGPO and BioCareSD as primary specialty drug partners

Connecticut's largest vitreoretinal practice said the tie-up adds AI-enabled drug management, distribution support and contracting flexibility as independent retina groups seek alternatives to legacy models.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.